Neuroprotective effects of the antioxidant LY231617 and NO synthase inhibitors in global cerebral ischaemia

Brain Research

Volumn 760, Issue 1-2, 1997, Pages 170-178

  O' Neill, Michael J ^a   Hicks, Caroline ^a   Ward, Mark ^a   Panetta, Jill A ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

3 Bromo 7 nitroindazole; Aminoguanidine; Cerebral ischaemia; Hippocampus; LY231617; Mongolian gerbil; Nitric oxide (NO)

Indexed keywords

2,6 DI TERT BUTYL 4 [(ETHYLAMINO)METHYL]PHENOL; 7 NITROINDAZOLE; AMINOGUANIDINE; ANTIOXIDANT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; THIOUREA DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PROTECTION; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; DRUG EFFECT; GERBIL; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NERVE CELL LESION; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ANIMALS; ANTIOXIDANTS; BRAIN ISCHEMIA; BUTYLATED HYDROXYTOLUENE; CELL COUNT; DISEASE MODELS, ANIMAL; GERBILLINAE; HIPPOCAMPUS; MALE; NITRIC OXIDE SYNTHASE;

EID: 0030806308     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00293-X     Document Type: Article

References (58)

1. Babbedge R.C., Bland-Ward P.A., Hart S.L., Moore P.K. Inhibition of rat cerebellar nitric oxide synthase by 7-nitroindazole and related substituted indazoles. Br. J. Pharmacol. 110:1993;225-228.
2. Beckman J.J., Beckman T.W., Chen J., Marshall D.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624.
3. Block F., Schmitt W., Schwarz M. The antioxidant LY231617 ameliorates functional and morphological sequelae induced by global ischaemia in rats. Brain Res. 694:1995;308-311.
4. Borgerding R.A., Murphy S. Expression of inducible nitric oxide synthase in cerebral endothelial cells is regulated by cytokine-activated astrocytes. J. Neurochem. 65:1995;1342-1347.
5. Bromont C., Marie C., Bralet J. Increased lipid peroxidation in vulnerable brain regions after transient forebrain ischemia in rats. Stroke. 20:1989;918-924.
6. Buisson A., Margaill I., Callebert J., Plotkine M., Boulu R.G. Mechanisms involved in the neuroprotective activity of a nitric oxide synthase inhibitor during focal cerebral ischemia. J. Neurochem. 61:1993;690-696.
7. G-nitro-L-arginine protects against ischaemia-induced increases in nitric oxide and hippocampal neurodegeneration in the gerbil. Eur. J. Pharmacol. 260:1994;191-200.
8. G-nitro-L-arginine methyl ester protects against lipid peroxidation in the gerbil following cerebral ischaemia. Eur. J. Pharmacol. 285:1995;203-206.
9. P.H. Chan, C.J. Epstein, F.R. Sharp, H. Kinouchi, H. Kamii, J. Gafni, S.F. Chen and E. Carlson, SOD-1 transgenic mice: A model for the study of cerebral ischemia, in: J. Krieglstein and H. Oberpichler-Schwenk (Eds.), Pharmacology of Cerebral Ischemia, Medpharm Scientific Publications, Stuttgart, 1994, pp. 277-286.
10. Choi D.W. Nitric oxide: Foe or friend to the injured brain? Proc. Natl. Acad. Sci. USA. 90:1993;9741-9743.
11. Clark W.M., Hazel J.S., Coull B.M. Lazaroids: CNS pharmacology and current research. Drugs. 50:1995;971-983.
12. Clemens J.A., Saunders R.D., Ho P.P., Phebus L.A., Panetta J.A. The antioxidant LY231617 reduces global ischemic neuronal injury in rats. Stroke. 24:1993;716-723.
13. Dalkara T., Yoshida T., Irikura K., Moskowitz M.A. Dual role of nitric oxide in focal cerebral ischemia. Neuropharmacology. 33:1994;1447-1452.
14. Dawson D.A., Graham D.I., McCulloch J., Macrae I.M. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia. Br. J. Pharmacol. 113:1994;247-253.
15. Dawson D.A. Nitric oxide and focal cerebral ischemia: Multiplicity of actions and diverse outcomes. Cerebrovascular Brain Metab. Rev. 6:1995;299-324.
16. Dawson V.L., Kizushi V.M., Huang P.L., Snyder S.H., Dawson T.M. Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J. Neurosci. 16:1996;2479-2487.
17. Garthwaite J., Garthwaite G., Palmer R.M.J., Moncada S. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur. J. Pharmacol. 172:1989;413-416.
18. Gaudet R.J., Alam I., Levine L. Accumulation of cyclooxygenase products of arachidonic acid metabolism in gerbil brain during reperfusion after bilateral common carotid artery occlusion. J. Neurochem. 35:1980;653-658.
19. Globus M.Y.-T., Busto R., Lin B., Schnippering H., Ginsberg M.D. Detection of free radical activity during transient global ischemia and recirculation: Effects of intraischemic brain temperature modulation. J. Neurochem. 65:1995;1250-1256.
20. Hall E.D. Inhibition of lipid peroxidation in central nervous trauma and ischemia. J. Neurol. Sci. 134:1995;79-83.
21. Hall E.D., Braughler J.M. Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation. Free Rad. Biol. Med. 6:1989;303-313.
22. Hellstrom H.O., Wanhainen A., Valtysson J., Persson L., Hillered L. Effect of tirilazad mesylate given after permanent middle cerebral artery occlusion in rat. Acta Neurochirurgica. 129:1994;188-192.
23. Hewett A.J., Csernansky C.A., Choi D.W. Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS. Neuron. 13:1994;487-494.
24. Huang Z., Huang P.L., Panahian N., Dalkara T., Fishman M.C., Moskowitz M.A. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 265:1994;1883-1885.
25. Huang Z.H., Huang P.L., May J.Y., Meng W., Ayata C., Fishman M.C., Moskowitz M.A. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J. Cereb. Blood Flow Metab. 16:1996;981-987.
26. Iadecola C., Zhang F., Xu S., Casey R., Ross M.E. Inducible nitric oxide synthase (iNOS) gene expression contributes to cerebral ischemic damage: A novel approach to stroke treatment using and iNOS inhibitor. Ann. Neurol. 38:1995;S286.
27. Inuoe N., Yamamoto Y.L., Ito Y., Clemens J.A., Panetta J.A., Diksic M. The efficacy of retrograde infusion with LY231617 in a rat middle cerebral artery occlusion model. Can. J. Neur. 23:1996;175-183.
28. Itzhak Y., Ali S.F. The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine induced neurotoxicity in vivo. J. Neurochem. 67:1996;1770-1773.
29. Karlsson B.R., Loberg E.M., Grogaard B., Steen P.A. The antioxidant tirilazad does not affect cerebral blood flow or histopathological changes following severe ischemia in rats. Acta. Neurol. Scand. 90:1994;256-262.
30. D. Lodge, A. Bond, M.J. O'Neill, C.A. Hicks, M. Jones, Stereoselective effects of 2,3-benzodiazepines in vivo: Electrophysiology and neuroprotection studies, Neuropharmacology, 35 (1996) 1681-1688.
31. Mésenge C., Verrecchia C., Allix M., Boulu R.G., Plotkine M. Reduction of the neurological deficit in mice with traumatic brain injury by nitric oxide synthase inhibitors. J. Neurotrauma. 13:1996;209-214.
32. Moncada S., Plamer R.M.J., Higgs E.A. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-142.
33. Moore P.K., Babbedge R.C., Wallace P., Gaffen Z.A., Hart S.L. 7-nitroindazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br. J. Pharmacol. 108:1993;296-297.
34. Moore P.K., Wallace P., Gaffen Z., Hart S.L., Babbedge R.C. Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: Antinociceptive and cardiovascular effects. Br. J. Pharmacol. 110:1993;219-224.
35. Nagafuji T., Sugiyama M., Muto A., Makino T., Miyauchi T., Nabata H. The neuroprotective effect of a potent and selective inhibitor of type I NOS (L-MIN) in a rat model of focal cerebral ischaemia. NeuroReport. 6:1995;1541-1545.
36. Nagafuji T., Sugiyama M., Makino T., Muto A., Naito S. Nitric oxide synthase in: Possible contribution of nitric oxide synthase activation in brain microvessels to cerebral ischemic injury. Mol. Chem. Neuropath. 26:1995;107-155.
37. Nowicki J.P., Duval D., Poignet H., Scatton B. Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur. J. Pharmacol. 204:1991;339-340.
38. O' Neill M.J., Hicks C., Ward M. Neuroprotective effects of 7-nitroindazole in the gerbil model of global cerebral ischaemia. Eur. J. Pharmacol. 310:1996;115-122.
39. Panahian N., Yoshida T., Huang P.L., Hedley-Whyte E.T., Dalkara T., Fishman M.C., Moskowitz M.A. Attenuated hippocampal damage after global cerebral ischemia in mice mutant in neuronal nitric oxide synthase. Neuroscience. 72:1996;343-354.
40. Panigrahi M., Sadguna Y., Shivakumar B.R., Kolluri S.V.R., Roy S., Packer L., Ravindranath V. α-Lipoic acid protects against reperfusion injury following cerebral ischemia in rats. Brain Res. 717:1996;184-188.
41. Park C.K., Hall E.D. Dose-response analysis of the 21-aminosteroid tirilazad mesylate (U-74006F) upon neurological outcome and ischemic brain damage in permanent focal cerebral ischemia. Brain Res. 645:1994;157-163.
42. G-nitro-L-arginine methyl ester decreases ischemic damage in reversible focal cerebral ischemia in hyperglycemic rats. Brain Res. 677:1995;204-212.
43. Schultz J.B., Matthews R.T., Muqit M.M.K., Browne S.E., Flint Beal M. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J. Neurochem. 64:1995;936-939.
44. Schultz J.B., Huang P.L., Matthews R.T., Passov D., Fishman M.C., Flint Beal M. Striatal malonate lesions are attenuated in neuronal nitric oxide synthase knockout mice. J. Neurochem. 67:1996;430-433.
45. Siesjö B.K., Agardh C.D., Bengtsson F. Free radicals and brain damage. Cerebrovasc. Brain Metab. Rev. 1:1989;165-211.
46. Siesjö B.K. Pathophysiology and treatment of focal cerebral ischemia, Part I: Pathophysiology J. Neurosurg. 77:1992;169-184.
47. Siesjö B.K. Pathophysiology and treatment of focal cerebral ischemia, Part II: Mechanisms and drug treatment. J. Neurosurg. 77:1992;337-354.
48. Smith S.E., Man C.M., Yip P.K., Tang E., Chapman A.G., Meldrum B.S. Anticonvulsant effects of 7-nitroindazole in rodents with reflex epilepsy may result from L-arginine accumulation or a reduction in nitric oxide or L-citrulline formation. Br. J. Pharmacol. 119:1996;165-173.
49. Strijbos P.J.L., Leach M.J., Garthwaite J. Vicious cycle involving Na+ channels, glutamate release, and NMDA receptors mediates delayed neurodegeneration through nitric oxide formation. J. Neurosci. 16:1996;5004-5013.
50. Szabó C., Southan G.J., Thiemermann C. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulphate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc. Natl. Acad. Sci. USA. 91:1994;12472-12476.
51. Tagaya M., Matsumoto M., Kitagawa K., Niiobe M., Ohtsuki T., Hata R., Ogawa S., Handa N., Mikoshhiba K., Kamda T. Recombinant human superoxide dismutase can attenuate ischemic neuronal damage in gerbils. Life Sci. 51:1992;253-259.
52. Traystman R.J., Kirsch J.R., Koehler R.C. Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J. App. Physiol. 71:1991;1185-1195.
53. Wolfe L.S. Eicosaniods, prostaglandins, thromboxanes, leuketrienes and other derivatives of carbo-20 unsaturated fatty acids. J. Neurochem. 38:1982;1-14.
54. Wright J.W., Clemens J.A., Panetta J.A., Smalstig E.B., Weatherly L.S., Kramar E.A., Pederson E.S., Mungall B.H., Harding J.W. Effects of LY231617 and angiotension IV on ischemia-induced deficits in circular water maze and passive avoidance performance in rats. Brain Res. 717:1996;1-11.
55. Xue D., Silvka A., Buchan A.M. Tirilazad reduces cortical infarction after transient, but not permanent focal cerebral ischemia in rats. Stroke. 23:1992;894-899.
56. Yoshida T., Limmroth V., Irikura K., Moskowitz M.A. The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not response to topical acetylcholine in pial vessels. J. Cereb. Blood Flow Metab. 14:1994;924-929.
57. Yoshida T., Waeber C., Huang Z., Moskowitz M.A. Induction of nitric oxide synthase activity in rodent brain following middle cerebral artery occlusion. Neurosci. Lett. 194:1995;214-218.
58. Zhang F., Casey R.M., Ross M.E., Iadecola C. Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion. Stroke. 27:1996;317-323.